Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1. (Q53598952)

16 May 2018

title

Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1. (English)

1 reference

16 May 2018

main subject

ICRF 193

1 reference

ChEBI release 2020-05-28

Iha Park

1

1 reference

16 May 2018

Hava Karsenty Avraham

series ordinal

2

1 reference

16 May 2018

language of work or name

English

0 references

publication date

21 April 2006

1 reference

16 May 2018

Experimental Cell Research

published in

1 reference

16 May 2018

volume

312

1 reference

16 May 2018

issue

11

1 reference

16 May 2018

page(s)

1996-2008

1 reference

16 May 2018

Cellular roles of dna topoisomerases: a molecular perspective

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Topoisomerase poisons: harnessing the dark side of enzyme mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Catalytic inhibitors of DNA topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Interaction of FANCD2 and NBS1 in the DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

MDC1 is a mediator of the mammalian DNA damage checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

53BP1, a mediator of the DNA damage checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

ATM is required for the cellular response to thymidine induced replication fork stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Etoposide and adriamycin but not genistein can activate the checkpoint kinase Chk2 independently of ATM/ATR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

ICRF-193, a catalytic inhibitor of DNA topoisomerase II, delays the cell cycle progression from metaphase, but not from anaphase to the G1 phase in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

The human decatenation checkpoint.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

A comparative study of genotoxic effects of anti-topoisomerase II drugs ICRF-193 and bufalin in Chinese hamster ovary cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Topoisomerase II poisoning by ICRF-193.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Genotoxicity of several clinically used topoisomerase II inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Focusing on foci: H2AX and the recruitment of DNA-damage response factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Histone H3 phosphorylation and cell division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

High yield of endoreduplication induced by ICRF-193: a topoisomerase II catalytic inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Induction of apoptosis by depletion of DNA topoisomerase IIalpha in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Association of BRCA1 with Rad51 in mitotic and meiotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Chromatin structure during the prereplicative phases in the life cycle of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Focal points for chromosome condensation and decondensation revealed by three-dimensional in vivo time-lapse microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Small molecule modulation of the human chromatid decatenation checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Ku antigen is required to relieve G2 arrest caused by inhibition of DNA topoisomerase II activity by the bisdioxopiperazine ICRF-193.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Regulation of the G2/M transition by p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

Decreased topoisomerase IIalpha expression confers increased resistance to ICRF-193 as well as VP-16 in mouse embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

DNA topoisomerase II sites in the histone H4 gene during the highly synchronous cell cycle of Physarum polycephalum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.02.029

10.1016/J.YEXCR.2006.02.029

7 January 2021

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018